The importance of clinical parameters when differentiating cholestatic hepatitis C virus from allograft rejection

Transplantation Proceedings

Volumn 37, Issue 10, 2005, Pages 4397-4402

  Neff, G W ^a   Shire, N ^a   Ruiz, P ^a   O'Brien, C ^a   Garcia, M ^a   Dela Garza, J ^a   Rudich, S R ^a   Reddy, K Rajender ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACLIZUMAB; METHYLPREDNISOLONE; PEGINTERFERON; PEGINTERFERON ALPHA2B; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RIBAVIRIN; TACROLIMUS;

ADULT; AGED; ANTIVIRAL ACTIVITY; ARTICLE; CHOLESTASIS; CHOLESTATIC HEPATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATION ANALYSIS; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DRUG SAFETY; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DYSFUNCTION; LIVER DISEASE; LIVER GRAFT; LIVER TRANSPLANTATION; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RETRANSPLANTATION; RETROSPECTIVE STUDY; TIME SERIES ANALYSIS; VIROLOGY; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; CHOLESTASIS; DEMOGRAPHY; GRAFT REJECTION; HEPATITIS C; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 29544437001     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.10.012     Document Type: Article

References (26)

1. M. Willems, H.J. Metselaar, H.W. Tilanus Liver transplantation and hepatitis C Transplant Intern 15 2002 61
2. M. Wali, R.F. Harrison, P.J. Gow Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C Gut 51 2002 248
3. M. Berenguer, M. Prieto, F. San Juan Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients Hepatology 36 2002 202
4. N.L. Ascher, J.R. Lake, J. Emond Liver transplantation for hepatitis C virus-related cirrhosis Hepatology 20 1994 24S
5. E.J. Gane, B.C. Portmann, N.V. Naoumov Long-term outcome of hepatitis C infection after liver transplantation N Engl J Med 334 1996 815
6. M. Berenguer Natural history of recurrent hepatitis C Liver Transpl 8 2002 S14
7. L.K. Schluger, P.A. Sheiner, S.N. Thung Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation Hepatology 23 1996 971
8. S.A. Taga, M.K. Washington, N. Terrault Cholestatic hepatitis C in liver allografts Liver Transpl Surg 4 1998 304
9. L. Belli, G. Dusheiko, K. Rolles Liver transplantation for chronic viral hepatitis Italian J Gastroent 23 1991 36
10. C.G. Asanza, C. Garcia-Monzon, G. Clemente Immunohistochemical evidence of immunopathogenetic mechanisms in chronic hepatitis C recurrence after liver transplantation Hepatology 26 1997 755
11. H.R. Rosen, D.R. Gretch, M. Oehlke Timing and severity of initial hepatitis C recurrence as predictors of long-term liver allograft injury Transplantation 65 1998 1178
12. A. Sanchez-Fueyo, J.C. Restrepo, L. Quinto Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft Transplantation 73 2002 56
13. E.J. Gane, B.C. Portmann, N.V. Naoumov Long-term outcome of hepatitis C infection after liver transplantation N Engl J Med 334 1996 815
14. J.Y. Leung, D.R. Abraczinskas, A.K. Bhan Recurrent allograft HCV presenting as acute cellular rejection successful management with interferon and ribavirin alone Clin Transpl 17 2003 275
15. A.L. Doughty, J.D. Spencer, Y.E. Cossart Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels Liver Transpl Surg 4 1998 15
16. K. Batts Distinguishing acute rejection from recurrent hepatitis C histologically in: recurrent liver disease after liver transplantation: diagnosis and management The AASLD/ILTS Transplant Course Poster presentation 1996 256
17. P.S. Randhawa, A.J. Demetris Hepatitis C virus infection in liver allografts Pathol Ann 30 1995 203
18. M.G. Pessoa, N. Bzowej, M. Berenguer Evolution of hepatitis C virus quasispecies in patients with severe cholestatic hepatitis after liver transplantation Hepatology 30 1999 1513
19. J.I. Arenas, J.F. Gallegos-Orozco, T. Laskus Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation J Infect Dis 189 2004 2037
20. V. Deshpande, E. Burd, K.L. Aardema High levels of hepatitis C virus RNA in native livers correlate with the development of cholestatic hepatitis in liver allografts and a poor outcome Liver Transpl 7 2001 118
21. D.R. Nelson, J.Y. Lau Host immune response in hepatitis C virus infection Viral Hepatitis Rev 2 1996 37
22. R.P. Gonzalez-Peralta, J.Y. Lau Do viral genotypes and HLA matching influence the outcome of recurrent hepatitis C virus infection after liver transplantation? Liver Transpl Surg 4 1998 104
23. E.J. Gane, N.V. Naoumov, K.P. Qian A longitudinal analysis of hepatitis C virus replication following liver transplantation Gastroenterology 110 1996 167
24. R.B. Freeman, S. Tran, Y.M. Lee Serum hepatitis C RNA titers after liver transplantation are not correlated with immunosuppression or hepatitis Transplantation 61 1996 542
25. Y. Zhu, K. Luo, L. Yu Clinical and histological features of fibrosing cholestatic hepatitis Chung Hua Kan Tsang Ping Tsa Chih 10 2002 434
26. Y. Maor-Kendler, K.P. Batts, L.J. Burgart Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases Transplantation 70 2000 292